
Robert O'Brien
Articles
-
Jul 31, 2024 |
newsbreak.com | Robert O'Brien
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments.
-
Jun 25, 2024 |
realcleardefense.com | Robert O'Brien
Making the Case for Trump’s Foreign PolicySi vis pacem, para bellum is a Latin phrase that emerged in the fourth century that means “If you want peace, prepare for war.” The concept’s origin dates back even further, to the second-century Roman emperor Hadrian, to whom is attributed the axiom, “Peace through strength—or, failing that, peace through threat.” Read Full Article »
-
Jun 12, 2024 |
ajmc.com | Robert O'Brien |Diana I. Brixner |Ashley Peterson |Paul Jeffrey
OpinionVideoJune 12, 2024Author(s):Panelists explore how payers choose between pharmacy and medical benefit designs for covering prescription digital therapeutics (PDTs), optimizing patient access and adoption, and discussing why the selected pathway was considered optimal for a specific PDT. Video content above is prompted by the following questions:How do payers determine the optimal pharmacy vs.
-
May 29, 2024 |
ajmc.com | Robert O'Brien |Diana I. Brixner |Ashley Peterson |Paul Jeffrey
Identifying the Most Impactful Disease Areas and Patient Populations for PDTsDiana Brixner, PhD, highlights the potential for prescription digital therapeutics (PDTs) to have impact in areas such as facilitating behavioral change for mental health conditions and strengthening adherence for complex disease states with intricate drug regimens.
-
May 22, 2024 |
ajmc.com | Robert O'Brien |Diana I. Brixner |Ashley Peterson |Paul Jeffrey
Paul Jeffrey, PharmD, presents the findings of a study, which investigated patient engagement and clinical outcomes associated with the use of prescription digital therapeutics (PDTs) in the treatment of substance use disorders, and discusses the need for further research to advance the efficacy and value of PDTs in this field.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →